Company / Return on Assets (ROA)
Maze Therapeutics, Inc. Return on Assets (ROA) History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-33.0%
FY2025
5-year range
-33.0% / -33.0%
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#144 of 213
Health Care
What the data says
At -33.0%, Maze Therapeutics, Inc.'s return on assets (roa) ranks #144 of 213 in the Health Care sector.
Based on SEC 10-K filings.
-33.0% in FY2025.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#144 of 213 in Health CareTop 68% of 213This company -33.0% Sector average -24.1%
▼
-36.8% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -33.0% | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026